Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP782421.RA_QWkziunNhRUepEuov1xQYmfXB6pS5aDsvxmUviISFg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP782421.RA_QWkziunNhRUepEuov1xQYmfXB6pS5aDsvxmUviISFg130_assertion type Assertion NP782421.RA_QWkziunNhRUepEuov1xQYmfXB6pS5aDsvxmUviISFg130_head.
- NP782421.RA_QWkziunNhRUepEuov1xQYmfXB6pS5aDsvxmUviISFg130_assertion description "[In contrast to patients with VHL, SDHB, and SDHD mutations, all patients with MEN 2 and NF1 presented with tumors characterized by increased plasma concentrations of metanephrine (indicating epinephrine production).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782421.RA_QWkziunNhRUepEuov1xQYmfXB6pS5aDsvxmUviISFg130_provenance.
- NP782421.RA_QWkziunNhRUepEuov1xQYmfXB6pS5aDsvxmUviISFg130_assertion evidence source_evidence_literature NP782421.RA_QWkziunNhRUepEuov1xQYmfXB6pS5aDsvxmUviISFg130_provenance.
- NP782421.RA_QWkziunNhRUepEuov1xQYmfXB6pS5aDsvxmUviISFg130_assertion SIO_000772 21262951 NP782421.RA_QWkziunNhRUepEuov1xQYmfXB6pS5aDsvxmUviISFg130_provenance.
- NP782421.RA_QWkziunNhRUepEuov1xQYmfXB6pS5aDsvxmUviISFg130_assertion wasDerivedFrom befree-20140225 NP782421.RA_QWkziunNhRUepEuov1xQYmfXB6pS5aDsvxmUviISFg130_provenance.
- NP782421.RA_QWkziunNhRUepEuov1xQYmfXB6pS5aDsvxmUviISFg130_assertion wasGeneratedBy ECO_0000203 NP782421.RA_QWkziunNhRUepEuov1xQYmfXB6pS5aDsvxmUviISFg130_provenance.